title: With better adjuvant therapy, does breast cancer stage still matter?
authors.affiliation: Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: Ines
authors.initials: I
authors.lastname: Vaz-Luis
authors.affiliation: Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA hal_burstein@dfci.harvard.edu.
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Burstein
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis